Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

FDA, Biogen Idec Say HIV-Positive People Should Not Take Skin Disorder Drug Amevive

November 14, 2005

FDA and the pharmaceutical company Biogen Idec on Thursday said HIV-positive individuals should not take the company's skin drug Amevive because it might lower their CD4+ T cell counts, Reuters reports (Reuters, 11/10). The drug is approved to treat moderate to severe psoriasis, an autoimmune skin disorder (Dow Jones/Boston Globe, 11/11). In a letter to health care providers last month, Biogen contraindicated Amevive for HIV-positive patients (Reuters, 11/10). Carmen Bozic, senior director of drug safety and risk management for Biogen, wrote that the contraindication says "Amevive should not be administered to patients with HIV. Amevive reduces CD4+ T lymphocyte counts, which might accelerate disease progression or increase complications of disease in these patients" (Biogen Idec letter, October 2005).

Back to other news for November 14, 2005


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2005 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement